
Niacinx Research & Consultancy Private Limited
About Niacinx Research & Consultancy Private Limited
Data last updated:
Niacinx Research & Consultancy Private Limited is a private limited company based in Greater Noida, Uttar Pradesh, India. It operates in the service-based operations segment of the business services sector. It was incorporated on 13 July 2018 and has been in existence for over 8 years.
The company is registered with the Registrar of Companies (ROC), Kanpur, under CIN U74999UP2018PTC106231. Its GSTIN is 09AAGCN1348H1ZE (Uttar Pradesh).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Mohit Sharma and Jangid Nidhi.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at B – 15 Grd Floor Tower B Paramout Golf Foreste Zeta 1, Greater Noida, Uttar Pradesh, India – 201306.
As per the financials filed for FY 2025, the company reported a revenue of ₹15.46 Lakh, a growth of 17% compared to the previous year. For the same year it recorded a net loss of ₹15,537 (net margin -1%) and EBITDA of -₹12,423 (EBITDA margin -0.8%). Revenue has grown at a compounded annual rate (CAGR) of 29% over three years and 39% over five years.
Company details
Contact details
Niacinx Research & Consultancy Private Limited's registered office is in Greater Noida, Uttar Pradesh. Its e-mail address is in the company report.
- Email
- Registered AddressB – 15 Grd Floor Tower B Paramout Golf Foreste Zeta 1, Greater Noida, Uttar Pradesh, India – 201306
- IndustryBusiness Services, Other Services, Miscellaneous Business Activities
To see the full contact details of Niacinx Research & Consultancy Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Niacinx Research & Consultancy is hospital and medical care. In detail, this covers other hospital and medical care activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| Q | Hospital and Medical Care | Q6 | Other Hospital and Medical Care Activities |
To see the full business activity and turnover split of Niacinx Research & Consultancy Private Limited, buy the company report.
Financials of Niacinx Research & Consultancy Private Limited
FY 2025 filings availableNiacinx Research & Consultancy Private Limited reported revenue of ₹15.46 Lakh (up 17% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 39% over five years, including 17% growth in the latest year. EBITDA fell 106% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹12,423 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹15,537 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | -0.8% | ||||
| Net Profit Margin | -1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Niacinx Research & Consultancy Private Limited, buy the company report.
Board of directors of Niacinx Research & Consultancy Private Limited
Niacinx Research & Consultancy has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Mohit Sharma | Director | 13 Jul 2018 | 8 Years 4 Months | Current |
| Jangid Nidhi | Director | 13 Jul 2018 | 8 Years 4 Months | Current |
Peer comparison
Niacinx Research & Consultancy Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (other hospital and medical care activities), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Dilson Healthcare Private Limited | ₹15.48 Lakh (FY 2025) | 95.0% | Ganjam, Odisha, India | |||
| Somno Medical Services Private Limited | ₹15.47 Lakh (FY 2024) | 40.0% | Jodhpur, Rajasthan, India | |||
| Veera Healthcare Private Limited | ₹15.47 Lakh (FY 2022) | 456.0% | Navi Mumbai, Maharashtra, India | |||
| As Thyropathcare Private Limited | ₹15.47 Lakh (FY 2021) | New Delhi, Delhi, India | ||||
| Cognious Labs Private Limited | ₹15.47 Lakh (FY 2025) | 4.0% | East Singhbhum, Jharkhand, India | |||
| Niacinx Research & Consultancy Private Limitedthis company | ₹15.46 Lakh (FY 2025) | -₹15,537 | -1% | 17.0% | Greater Noida, Uttar Pradesh, India | |
| Adinika Healthcare Private Limited | ₹15.44 Lakh (FY 2022) | 228.0% | Mumbai, Maharashtra, India | |||
| Regpal Pharma Consulting Private Limited | ₹15.42 Lakh (FY 2023) | 928.0% | Newpanvel, Maharashtra, India | |||
| Idca Healthcare Private Limited | ₹15.41 Lakh (FY 2022) | Baran, Rajasthan, India | ||||
| Rithika Surabhi Medicare Private Limited | ₹15.38 Lakh (FY 2023) | 296.0% | Tirupati, Andhra Pradesh, India | |||
| Medicant Hospital and Research Centre Private Limited | ₹15.38 Lakh (FY 2024) | 67.0% | Delhi, India |
To see the full peer comparison of Niacinx Research & Consultancy Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Niacinx Research & Consultancy Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Niacinx Research & Consultancy Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Niacinx Research & Consultancy has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AAGCN1348H1ZE | Uttar Pradesh | Active | 04 Aug 2018 |
To see the full GST registrations and return filing status of Niacinx Research & Consultancy Private Limited, buy the company report.
Recent activity
Niacinx Research & Consultancy Private Limited has 2 board changes on record since 2018: 2 appointments. The latest: Jangid Nidhi was appointed as Director on 13 Jul 2018.
Frequently asked questions
Niacinx Research & Consultancy is an active private limited company based in Greater Noida, Uttar Pradesh, India. The company works in other services, within the business services industry. It was incorporated on 13 July 2018 (8+ years old) and is registered under CIN U74999UP2018PTC106231.
Niacinx Research & Consultancy has 2 current directors:
- Mohit Sharma - Director
- Jangid Nidhi - Director
The latest financial statements of Niacinx Research & Consultancy on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2019 are in the company report.
The GSTIN of Niacinx Research & Consultancy is 09AAGCN1348H1ZE, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of Niacinx Research & Consultancy is U74999UP2018PTC106231. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Niacinx Research & Consultancy was incorporated on 13 July 2018, making it 8+ years old. It is registered with the Registrar of Companies, Kanpur.
The peers of Niacinx Research & Consultancy by revenue are Dilson Healthcare Private Limited, Somno Medical Services Private Limited, Veera Healthcare Private Limited, As Thyropathcare Private Limited, Cognious Labs Private Limited and 5 more, all in the same principal business activity (other hospital and medical care activities).
Jangid Nidhi was appointed as Director on 13 Jul 2018. Mohit Sharma was appointed as Director on 13 Jul 2018.
The registered office of Niacinx Research & Consultancy is at B – 15 Grd Floor Tower B Paramout Golf Foreste Zeta 1, Greater Noida, Uttar Pradesh, India – 201306.
Niacinx Research & Consultancy operates in the business services industry, in the other services segment.
Niacinx Research & Consultancy can be reached at its registered office: B – 15 Grd Floor Tower B Paramout Golf Foreste Zeta 1, Greater Noida, Uttar Pradesh, India – 201306.

